Signal active
Organization
Contact Information
Overview
Rapid Oxygen Company is a medtech company to provide a safe and reliable portable emergency oxygen system. The company manufactures a patented FDA-cleared emergency oxygen solution called the R15 which is the only emergency oxygen device that is non-explosive, portable, easy to use and doesn’t require a power source.
The R15 meets or exceeds FDA guidelines for portable chemical oxygen generators, through Rapid Oxygen’s recently patented delivery system. The R15 produces 100% humidified oxygen at flows greater than 6 liters/minute for more than 15 minutes with acceptable safe temperatures on all of its’ surfaces.
About
Hardware, Medical, Computer, Manufacturing, Public Safety, Medical Device, First Aid
2016
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Rapid Oxygen Company headquartered in United States, North America, operates in the Hardware, Medical, Computer, Manufacturing, Public Safety, Medical Device, First Aid sector. The company focuses on Hardware and has secured $462.3M in funding across 84 round(s). With a team of 11-50 employees, Rapid Oxygen Company is actively contributing to advancements in Hardware. Their latest funding round, Venture Round - Rapid Oxygen Company, raised $500.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
1
0
$5.5M
Details
0
Rapid Oxygen Company has raised a total of $5.5M in funding over 0 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|
Investors
Rapid Oxygen Company is funded by 4 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Michael Wisniewski | - | FUNDING ROUND - Michael Wisniewski | 500.0K |
Kevin Crowley | - | FUNDING ROUND - Kevin Crowley | 500.0K |
Rapid Oxygen Company | - | FUNDING ROUND - Rapid Oxygen Company | 500.0K |
Connecticut Innovations | - | FUNDING ROUND - Connecticut Innovations | 500.0K |
Recent Activity
There is no recent news or activity for this profile.